The vasoactive effect of new oxime-nitrate derived from isosorbide-5-mononitrate
Vazoaktivna svojstva novog oksim-nitrata dobijenog iz izosorbid-5-mononitrata
Извор:
Arhiv za farmaciju, 2002, 52, 4, 628-629Издавач:
- Savez farmaceutskih udruženja Srbije, Beograd
Институција/група
PharmacyTY - CONF AU - Stepanović-Petrović, Radica AU - Tokić-Vujošević, Zorana AU - Milovanović, Slobodan R. AU - Tomić, Maja PY - 2002 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/407 PB - Savez farmaceutskih udruženja Srbije, Beograd C3 - Arhiv za farmaciju T1 - The vasoactive effect of new oxime-nitrate derived from isosorbide-5-mononitrate T1 - Vazoaktivna svojstva novog oksim-nitrata dobijenog iz izosorbid-5-mononitrata VL - 52 IS - 4 SP - 628 EP - 629 UR - https://hdl.handle.net/21.15107/rcub_farfar_407 ER -
@conference{ author = "Stepanović-Petrović, Radica and Tokić-Vujošević, Zorana and Milovanović, Slobodan R. and Tomić, Maja", year = "2002", publisher = "Savez farmaceutskih udruženja Srbije, Beograd", journal = "Arhiv za farmaciju", title = "The vasoactive effect of new oxime-nitrate derived from isosorbide-5-mononitrate, Vazoaktivna svojstva novog oksim-nitrata dobijenog iz izosorbid-5-mononitrata", volume = "52", number = "4", pages = "628-629", url = "https://hdl.handle.net/21.15107/rcub_farfar_407" }
Stepanović-Petrović, R., Tokić-Vujošević, Z., Milovanović, S. R.,& Tomić, M.. (2002). The vasoactive effect of new oxime-nitrate derived from isosorbide-5-mononitrate. in Arhiv za farmaciju Savez farmaceutskih udruženja Srbije, Beograd., 52(4), 628-629. https://hdl.handle.net/21.15107/rcub_farfar_407
Stepanović-Petrović R, Tokić-Vujošević Z, Milovanović SR, Tomić M. The vasoactive effect of new oxime-nitrate derived from isosorbide-5-mononitrate. in Arhiv za farmaciju. 2002;52(4):628-629. https://hdl.handle.net/21.15107/rcub_farfar_407 .
Stepanović-Petrović, Radica, Tokić-Vujošević, Zorana, Milovanović, Slobodan R., Tomić, Maja, "The vasoactive effect of new oxime-nitrate derived from isosorbide-5-mononitrate" in Arhiv za farmaciju, 52, no. 4 (2002):628-629, https://hdl.handle.net/21.15107/rcub_farfar_407 .